会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • SYSTEMS AND METHODS FOR MAKING HEPATOCYTES FROM EXTRAHEPATIC SOMATIC STEM CELLS AND USE THEREOF
    • 用于从外来静脉干细胞制备肝细胞的系统和方法及其用途
    • US20090317365A1
    • 2009-12-24
    • US12489760
    • 2009-06-23
    • Oscar Kuang-Sheng LEETom Kwang-Chun Kuo
    • Oscar Kuang-Sheng LEETom Kwang-Chun Kuo
    • A61K35/12C12N5/06C12Q1/02C12Q1/48C12Q1/42C12Q1/26
    • G01N33/5067A61K35/407C12N5/067C12N2500/25C12N2500/38C12N2501/06C12N2501/113C12N2501/115C12N2501/119C12N2501/12C12N2501/155C12N2501/39C12N2503/02C12N2506/1353
    • A method for making hepatocytes from extrahepatic somatic stem cells comprises: a) culturing somatic stem cells in a medium comprising hepatic growth factor to cause the stem cells to differentiate toward hepatocytes; b) culturing cells from a) in a medium comprising HGF and oncostatin M to facilitate the cell differentiation toward hepatocytes; and c) culturing cells from b) in a medium comprising oncostatin M to cause the differentiated cells to mature into hepatocytes, thereby producing a cell population that has morphological features of hepatocytes and at least four of the following characteristics: i) antibody-detectable expression of albumin; ii) real-time reverse transcriptase-polymerase chain reaction-detectable expression of α-fetoprotein, HNF-1α, HNF-3β, HNF-4, HNF-6, α1-antitrypsin, alkaline phosphatase, tryptophan 2,3-dioxygenase, tyrosine aminotransferase, cytochrome P450 family 2 subfamily E polypeptide 1, glutamine synthetase, and/or low density lipoprotein receptor; iii) urea secretion; iv) cytochrome p450 enzyme activity; v) glycogen storage; and vi) low density lipoprotein uptake.
    • 从肝外体细胞干细胞制备肝细胞的方法包括:a)在包含肝细胞生长因子的培养基中培养体细胞干细胞,使干细胞分化成肝细胞; b)在包含HGF和制瘤素M的培养基中培养来自a)的细胞,以促进细胞向肝细胞分化; 和c)在包含制瘤素M的培养基中培养来自b)的细胞以使分化的细胞成熟为肝细胞,从而产生具有肝细胞形态特征和至少四种以下特征的细胞群:i)抗体可检测的表达 白蛋白 ii)甲胎蛋白,HNF-1α,HNF-3β,HNF-4,HNF-6,α1-抗胰蛋白酶,碱性磷酸酶,色氨酸2,3-双加氧酶,酪氨酸的实时逆转录酶 - 聚合酶链反应可检测的表达 氨基转移酶,细胞色素P450家族2亚科E多肽1,谷氨酰胺合成酶和/或低密度脂蛋白受体; iii)尿素分泌; iv)细胞色素p450酶活性; v)糖原储存; 和vi)低密度脂蛋白摄取。
    • 4. 发明授权
    • Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof
    • 用于从肝外体细胞干细胞制备肝细胞的系统和方法及其用途
    • US08062632B2
    • 2011-11-22
    • US12489760
    • 2009-06-23
    • Oscar Kuang-Sheng LeeTom Kwang-Chun Kuo
    • Oscar Kuang-Sheng LeeTom Kwang-Chun Kuo
    • A01N63/00A01N65/00
    • G01N33/5067A61K35/407C12N5/067C12N2500/25C12N2500/38C12N2501/06C12N2501/113C12N2501/115C12N2501/119C12N2501/12C12N2501/155C12N2501/39C12N2503/02C12N2506/1353
    • A method for making hepatocytes from extrahepatic somatic stem cells comprises: a) culturing somatic stem cells in a medium comprising hepatic growth factor to cause the stem cells to differentiate toward hepatocytes; b) culturing cells from a) in a medium comprising HGF and oncostatin M to facilitate the cell differentiation toward hepatocytes; and c) culturing cells from b) in a medium comprising oncostatin M to cause the differentiated cells to mature into hepatocytes, thereby producing a cell population that has morphological features of hepatocytes and at least four of the following characteristics: i) antibody-detectable expression of albumin; ii) real-time reverse transcriptase-polymerase chain reaction-detectable expression of α-fetoprotein, HNF-1α, HNF-3β, HNF-4, HNF-6, α1-antitrypsin, alkaline phosphatase, tryptophan 2,3-dioxygenase, tyrosine aminotransferase, cytochrome P450 family 2 subfamily E polypeptide 1, glutamine synthetase, and/or low density lipoprotein receptor; iii) urea secretion; iv) cytochrome p450 enzyme activity; v) glycogen storage; and vi) low density lipoprotein uptake.
    • 从肝外体细胞干细胞制备肝细胞的方法包括:a)在包含肝细胞生长因子的培养基中培养体细胞干细胞,使干细胞分化成肝细胞; b)在包含HGF和制瘤素M的培养基中培养来自a)的细胞,以促进细胞向肝细胞分化; 和c)在包含制瘤素M的培养基中培养来自b)的细胞以使分化的细胞成熟为肝细胞,从而产生具有肝细胞形态特征和至少四种以下特征的细胞群:i)抗体可检测的表达 白蛋白 ii)甲胎蛋白,HNF-1α,HNF-3和bgr,HNF-4,HNF-6,α1-抗胰蛋白酶,碱性磷酸酶,色氨酸2,3-双加氧酶,实时逆转录酶 - 聚合酶链反应检测的表达, 酪氨酸氨基转移酶,细胞色素P450家族2亚家族E多肽1,谷氨酰胺合成酶和/或低密度脂蛋白受体; iii)尿素分泌; iv)细胞色素p450酶活性; v)糖原储存; 和vi)低密度脂蛋白摄取。